GlassScriptPhysician profile
Jordan Bilbrew
NPI 1578022893
$1,752.99
in general payments reported to CMS, 2019-2025
11 companies · $858 in 2025
The $858 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $245 · 2023: $417 · 2024: $233 · 2025: $858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,371 · Entertainment: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,370.94 |
| Entertainment | $136.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $325.99 | 2025 | Cvac Aspiration System |
| Boston Scientific Corporation | $255.17 | 2022-2023 | Lithovue |
| Teleflex LLC | $253.77 | 2025 | Barrigel, Deflux Metal Needle |
| Photocure INC | $141.26 | 2025 | Cysview |
| Edap Technomed INC | $136.63 | 2025 | |
| Olympus America INC. | $133.73 | 2022 | |
| Urogen Pharma, INC. | $121.84 | 2024 | |
| Palette Life Sciences, INC. | $113.92 | 2023 | |
| Merck Sharp & Dohme LLC | $111.14 | 2024 | Keytruda |
| Endo Pharmaceuticals INC. | $96.00 | 2023 | Xiaflex |
| Coloplast Corp | $63.54 | 2023 | Speedicath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Bilbrew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.